Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Canadian National Railway $750 million notes offering
We advised the company on the investment-grade debt offering
Janus Henderson $400 million senior notes offering
The investment-grade notes are due 2034
CK Hutchison Holdings $1 billion notes offering
We advised CK Hutchison Holdings on the investment-grade notes offering
Norwegian Cruise Line $315 million senior notes offering
The high-yield notes are due 2030
Bunge Global $2 billion senior notes offering
The investment-grade notes are due 2028, 2029 and 2034
Province of Ontario $2 billion global bond offering
The investment-grade bonds are due 2029
MBX Biosciences $188 million IPO
The shares are listed on the Nasdaq Global Select Market
W.W. Grainger $500 million notes offering
The investment-grade notes are due 2034
Terns Pharmaceuticals $173 million stock and pre-funded warrants offering
The shares are listed on the Nasdaq Global Select Market